Jacek L. Mostwin, M.D., D. Phil. (Oxon), Medical Editor
Dr. Mostwin, a urological surgeon at Johns Hopkins, maintains a busy medical practice focusing on prostate cancer. He has performed more than 2,300 radical prostatectomies over the years. Among his major research interests are urinary continence issues and bladder function. Most of Dr. Mostwin’s scientific publications have dealt with lower urinary tract problems.

We have assembled a prestigious medical advisory board comprised of faculty members at Johns Hopkins to provide you with information that can improve your quality of life.

Alan W. Partin, M.D., Ph.D.
is a renowned surgeon, researcher, and teacher whose work has influenced urological advances. Dr. Partin, Professor and Director of the James Buchanan Brady Urological Institute at Johns Hopkins, has both a basic science and clinical interest in prognosis prediction for men with prostate cancer. He is a dedicated scientist. Over the years, he has focused his scientific attention on development and testing of new and existing methods for predicting the aggressiveness of prostate cancers so that rational treatment decisions can be made by both patients and physicians.
The Partin tables, the diagnostic prostate cancer nomograms that Dr. Partin developed in 1993, now help prostate cancer patients the world over get an accurate prediction of their likelihood of being cured.

H. Ballentine Carter, M.D.
is a Professor of Urology and Oncology at The Johns Hopkins Medical School, and a practicing surgeon. He is a recognized expert in the diagnosis, staging, and treatment of prostate cancer. Dr. Carter pioneered the concept of PSA changes (PSA velocity) as a marker of prostate cancer presence, and the use of free PSA to predict the behavior of prostate cancer.
Dr. Carter is working closely with colleagues at the Baltimore Longitudinal of Study of Aging (National Institute of Aging) to track the incidence of prostate disease in men over time, as they age. These longitudinal studies could help identify risk factors involved in the development of prostate disease.

FREE REPORT #1:
BPH: Reviewing the Options.
The latest treatments for benign prostate hyperplasia, with emphasis on minimally-invasive techniques.

FREE REPORT #2:
Diet and Prostate Health.
Important dietary links and specific nutritional guidelines for preventing—and coping with—prostate disorders.

FREE REPORT #3:
Treating Overactive Bladder.
An in-depth look at current options for treating OAB—including a close-up look at a new generation of medications.

FREE REPORT #4:
Chronic Prostatitis: New Research, Renewed Hope.
Breakthrough research studies point the way to important new therapies you need to know about.

FREE REPORT #5:
The Radical Prostatectomy.
Absolutely essential reading for anyone facing the prospect of surgery or its after effects.

5 FREE Johns Hopkins Special Reports covering the latest medical discoveries on preventing, treating and reversing prostate disorders.

A risk-FREE Preview of a remarkable new health information resource.

The physicians and researchers at the Johns Hopkins Brady Urological Institute aspire to provide the best medical care for patients through world-class medical practice, research and education.

Under the direction of chairman Dr. Alan Partin, the clinical facility is the world leader in treating prostate cancer, benign prostate hyperplasia, erectile dysfunction, incontinence and bladder dysfunction.

The research faculty, under the guidance of Dr. Robert H. Getzenberg, is renowned for breakthrough research in areas ranging from tumor suppressors and gene therapy to cell adhesion molecules and tumor markers.

A Personal Letter from Dr. Mostwin, which reviews critical prostate developments of the past few weeks. Treatment strategies. Early intervention options. New clinical trials. Reports from urological conferences that are helping to improve and prolong men’s lives.

In-Depth Reports give you the latest information about everything from new medications and preventive measures to dietary guidelines and minimally invasive procedures. Informative articles from leading prostate experts. No sensationalism. No hype. No hard-to-decipher medical jargon — just the facts you need to make better-informed health decisions.

Grand Rounds let readers pose detailed questions about difficult health care decisions — and provide detailed answers from top Hopkins urology specialists. The Bulletin helps you recognize early warning signs… communicate more effectively with your physician… understand your options.

You’ll also receive 5 Complimentary Special Reports to help you take control of prostate medical care: BPH: Reviewing the Options… Diet and Prostate Health… Treating Overactive Bladder… Chronic Prostatitis: New Research, Renewed Hope… The Radical Prostatectomy.

Evaluate The Johns Hopkins Prostate Bulletin on a risk-FREE basis — along with five FREE Prostate Special Reports. If you're dissatisfied in any way, simply notify us that you wish to cancel — and you'll receive a prompt refund of your entire subscription cost, no questions asked. The five Special Reports are yours to keep in any case.

Dear Friend,
Our mandate at The Johns Hopkins Hospital is to conquer prostate cancer. In this vital mission, we pride ourselves on being the best: Year after year, Hopkins is rated #1 in the country by U.S. News & World Report. The caring surgeons, scientists, and nurses with whom I’m privileged to work are the reason why. Together, we’ve been honored with hundreds of grants from the National Cancer Institute for research on prostate cancer. Hopkins has continually led the way: we were the first to perform TURP; and it was at Hopkins that Dr. Patrick C. Walsh perfected the nerve-sparing radical prostatectomy, and Dr. Alan W. Partin developed his breakthrough method for predicting the aggressiveness of prostate cancers.

As the chief medical editor of the Prostate Bulletin, it’s my pleasure to invite you to receive, direct from our renowned Hopkins team, the latest and most accurate prostate information. I’m also anxious to hear your questions and concerns, so don’t forget to write them on the enclosed order card.

To your good health,

H. Ballentine Carter, M.D.
Medical Advisor, The Johns Hopkins Prostate Bulletin

Introducing the quarterly Johns Hopkins Prostate Bulletin Get the Latest Prostate Health Breakthroughs... PLUS 5 FREE Special Reports. The Johns Hopkins Prostate Bulletin: like having an in-depth consultation with a leading Hopkins specialist.

From the desk of
Stuart Jordan
Publisher, The Johns Hopkins Prostate Bulletin

Dear Friend,

Your health is our foremost priority at Johns Hopkins, America's #1 Best Hospital for 18 consecutive years.

That's why we publish the quarterly Johns Hopkins Prostate Bulletin, covering such crucial topics as prostate cancer, enlarged prostate, prostatitis, erectile dysfunction, and more, and why we're offering you these five FREE Special Reports as instant PDF downloads you can start reading now:

• FREE Special Report #1: BPH: Reviewing the Options. A must-read report on treatments for BPH (benign prostatic hyperplasia, also known as an enlarged prostate), which affects 50% of men by the time they reach age 50. Learn more about the minimally-invasive BPH treatment options.
  
  
• FREE Special Report #2: Diet and Prostate Health. Research appears to indicate that up to 90% of all prostate cancers have dietary links. Our Special Report includes specific nutritional guidelines for preventing — and coping with — prostate disorders.
  
  
• FREE Special Report #3: Treating Overactive Bladder. An in-depth look at current options for treating OAB — including a close-up on the new generation of medications that have fewer side effects than the more commonly prescribed drugs.
  
  
• FREE Special Report #4: Chronic Prostatitis: New Research, Renewed Hope. If you're one of the millions of American men who suffer from this frustrating condition, don't despair. Breakthrough research is pointing the way to important new therapies for treating your prostatitis.
  
  
• FREE Special Report #5: The Radical Prostatectomy. Written by Dr. Patrick C. Walsh, M.D., Urologist-in-Chief of the James Buchanan Brady Urological Institute at Johns Hopkins, and author of "Guide to Surviving Prostate Cancer," this special report is essential reading for anyone who needs to know more about prostate cancer surgery and its aftereffects.
  

All five FREE PDF Special Reports, available as instant PDF downloads, are yours to keep with our compliments as your introduction to The Johns Hopkins Prostate Bulletin, the most comprehensive, up-to-the-minute review of advances in the treatment of prostate cancer, BPH and prostatitis.

Each issue of The Prostate Bulletin brings you the latest research findings, clinical trials results, and detailed, in-depth analyses by our Hopkins experts, all designed especially with you in mind as you sift through all your treatment options to make crucial decisions about your prostate health.

As publisher of The Johns Hopkins Prostate Bulletin, working with doctors and professors of urology at America's #1 urology center, at America's #1 Best Hospital, I am constantly impressed by the wealth of new therapies, important breakthroughs, and newly-discovered preventive measures available to men at high risk for prostate cancer and BPH, or who are undergoing treatment for them.

Yet for the average person, the information has simply been inaccessible — hidden in obscure medical journals or buried in minuscule articles in the back of the daily newspaper. Even many physicians may not have ready access to up-to-the-minute research in this highly specialized field.

As the nation's leading center for prostate care and research, Johns Hopkins' James Buchanan Brady Urological Institute is in a unique position to evaluate and disseminate the very latest information concerning advances in prostate treatment.

Dr. Jacek Mostwin leads our team of world-class prostate specialists as chief medical editor of a remarkable publication created with you in mind, to present you with the most important prostate breakthroughs you need to know now in your quest for the best treatments for your prostate cancer, BPH, or prostatitis.

The Johns Hopkins Prostate Bulletin has one clear mission: to provide you with the kind of authoritative, leading-edge information you need to take charge of your prostate health intelligently and effectively.

The Johns Hopkins Prostate Bulletin helps you make the most educated decisions possible, and saves you both time and money, reviewing as it does all the major medical journals and conferences papers on prostate cancer, BPH and prostatitis, as well as ED and OAB, into one essential quarterly prostate reference. Graphs, charts, diagrams are also presented in order to illustrate this cutting-edge information.

And that's not all. In each issue of The Johns Hopkins Prostate Bulletin, you'll also receive an in-depth special report on key prostate health topics; the Doctor's Letter, a review of what's happened in the world of urology since the last issue; plus, "Grand Rounds," real questions from subscribers just like you, with real answers from our specialists.

The Johns Hopkins Prostate Bulletin is designed to be like a consultation with a Hopkins specialist, offering you unprecendented access to this level of world-renowned expertise in the field of urology.

The Johns Hopkins Prostate Bulletin brings you eye-opening reports about new therapeutic avenues... advance news of clinical trials in which you can participate... detailed answers to subscribers' most pressing questions and concerns... revealing research findings about nutrition, supplementation, lifestyle influences and diagnostic tools... and the latest news from urological and cancer conferences around the world.

The Johns Hopkins Prostate Bulletin has a single expert focus on prostate health issues, and the preservation of your health and quality of life, all presented clearly, without mysterious medical jargon — so you can understand your options, and what the latest advances in prostate cancer treatments and BPH treatments mean to you.

And all this is delivered to your door quarterly via Priority Mail, so you can be sure the news is fresh, current, and can start to use it right away in your quest for the best prostate disease treatment possible.

This can literally be life-changing information — especially if you fall within the prostate cancer high-risk target zone, which includes men over 40, African-Americans, and any male with a family history of prostate problems.

In recent issues, The Johns Hopkins Prostate Bulletin subscribers have learned about:

• The differences between expectant management (also know as watchful waiting), radical prostatectomy, brachytherapy, and EBRT (external beam radiation therapy) for prostate cancer, and questions you need to ask, AND answer yourself, before you choose any prostate cancer treatment.
  
  
• Exciting breakthroughs in the early detection of prostate cancer, which could elimate the 'guesswork' if your prostate biopsy turns out to be inconclusive. Human clinical trials are expected to be underway shortly. The Johns Hopkins Prostate Bulletin will provide contacts for these and other clinical trials at Johns Hopkins and other leading medical institutions as soon as they are announced.
  
  
• New evidence that the progression of prostate cancer may actually be slowed by dietary changes. One study published in the Journal of Urology found that tumor cells from men taking flaxseed in combination with a lowfat diet appeared to be growing more slowly and dying more quickly than those of the control group.
  
  
• PSA testing controversies, and guidelines for who should have their PSA tested, when, and how often
  
  
• What to expect from a prostate biopsy: before, during, and after the procedure, and when to get a second, or even third opinion
  
  
• Expert guidance for dealing with erectile dysfunction and restoring intimacy and sexual satisfaction after prostate surgery.
  


• Important prostate issues to consider if you’re contemplating testosterone replacement therapy. The good news: most urologists now recommend replacement therapy for men with low testosterone levels — provided careful follow-up examinations are maintained.
  
  
• Must-read comparison of the new robotic and laparoscopic prostatectomies with the traditional radical prostatectomy. The latest reports from the annual meeting of the American Urological Association offer important insights about the relative merits of both approaches for curing prostate cancer and maintaining quality of life.
  
  
• The latest refinements in radical prostatectomy which are specifically designed to be as nerve-sparing as possible.
  
  
• Why a new use of an oral hormonal medication may represent an important breakthrough in prostate cancer treatment.
  
  
• How a team of scientists and physicians is zeroing in on an improved Prostate Specific Antigen (PSA) test — one which will reduce false positive readings and provide greater accuracy in predicting which men have PSA elevations due to benign prostate enlargement, and which are due to prostate cancer. The Johns Hopkins Prostate Bulletin readers will be kept apprised of their success as the data is reported.
  
  
• Five questions you should ask your surgeon if you are facing a radical prostatectomy. If he answers negatively to any one of them, consider seeking treatment elsewhere.
  
  
• Overactive bladder? You’re not alone — an estimated 17 million Americans, most under the age of 65, are affected by OAB. Learn the causes and triggers of overactive bladder, and what can be done to treat it.
  
  
• The biggest mistake physicians make in prescribing drugs for prostate enlargement. Important reading for anyone taking Hytrin, Cardura, Flomax, Avodart, or Minipress.
  
  
• The pros and cons of medications, minimally-invasive therapies, and surgical alternatives in treating benign prostatic hyperplasia (BPH) — the most common benign tumor found in men.
  
  
• The many surgical treatment options now available for BPH; a detailed comparison, with essential questions to ask when deciding on your BPH treatment.
  
  
• The good news about selenium. One large study reported that the incidence of prostate cancer was reduced by 63 percent in those taking selenium supplements. The Johns Hopkins Prostate Bulletin subscribers are updated regularly on the latest nutritional studies — and receive expert guidance on optimum dosages and types.
  
  
• Where to find national listings of clinical trials of new therapies for BPH and prostate cancer — and how you can apply to take part in them.
  
  
• Advance prostate cancer treatment options: how effective are they?
  
  
• New drugs for advanced prostate cancer: newly-approved, and those about to start their clinical trials.
  
  
• A worldwide review of the latest breakthroughs on prostate cancer treatments. Essential reading if you have just been diagnosed, and even if you have recurrent or advanced prostate cancer.
  
  
• How Gleason Scores are determined, how a 3 + 4=7 differs from a 4+3=7, and why rendering an accurate Gleason Score and prostate cancer diagnosis can be so difficult for a pathologist. And what to do if your prostate biopsy comes back as inconclusive.
  
  
• The Partin Tables and how they help determine your prostate cancer prognosis and can help you with your prostate cancer treatment decisions.
  
  

If you haven't heard about this latest prostate news we've listed above, or don't have the answers to your essential questions about your treatment options for BPH or prostate cancer, you owe it to yourself and your loved ones to subscribe now to The Johns Hopkins Prostate Bulletin.

The most important prostate publication you’ll ever read —
yet your subscription is entirely risk-FREE.

If you or a loved one has reason to be concerned about prostate health, The Johns Hopkins Prostate Bulletin is the most essential resource you’ll ever subscribe to — even if you’ve never been diagnosed with a health-threatening prostate condition.

It's a fact: if you live long enough, you will develop prostate health issues. And prostatitis can affect men at any age.

The Johns Hopkins Prostate Bulletin will keep you abreast of the latest studies, therapies, and breakthroughs, alert you to clinical trials in which you can participate, and bring you the latest news from urological and cancer conferences around the world. All without medical jargon — so you can clearly understand what the advances in prostate treatments and prostate cancer prevention mean to you.

This can literally be life-saving information — yet your subscription to The Johns Hopkins Prostate Bulletin is entirely risk-FREE. If you are dissatisfied with the Bulletin at any time, for any reason — simply contact Customer Service for a prompt and complete refund, no questions asked.

The five FREE Prostate Bulletin Special Reports
are yours to keep, even if you decide not to continue.

Recently, we issued five Special Reports on prostate health issues that I consider so important, I want you to have them immediately as instant PDF downloads as soon as you subscribe to your risk-FREE Prostate Bulletin. All five will be included on a complimentary basis with your subscription — and they’re yours to keep even if you don’t continue as a subscriber to The Johns Hopkins Prostate Bulletin. You’ll receive Special Reports on:

• FREE Special Report #1: BPH: Reviewing the Options. A must-read report on treatment options for benign prostate enlargement. From watchful waiting and pharmaceutical therapies, to surgical solutions, this comprehensive guide explains the alternatives and lists the pros and cons of each.
  
  
• FREE Special Report #2: Diet and Prostate Health. Researchers now think up to 90% of all prostate cancers have dietary links. Our Special Report includes the latest dietary guidelines for preventing cancer, and possibly even slowing its growth.
  
  
• FREE Special Report #3: Treating Overactive Bladder. An in-depth look at the complete range of current options for treating OAB — including some your physician may not yet be familiar with.
  
  
• FREE Special Report #4: Chronic Prostatitis: New Research, Renewed Hope. If you’re one of the millions of American men who suffer from this frustrating condition, don’t despair. Breakthrough research studies are pointing the way to promising new therapeutic avenues.
  
  
• FREE Special Report #5: The Radical Prostatectomy. If you’re facing prostate surgery, and what to know about what to expect before, during, and after, this Special Report by a leading authority in the field is a must-reading.
  

A risk-FREE opportunity
to improve your medical outlook —
and save $46!

All five Special Reports are yours to keep without risk, obligation or further commitment as a gift of good health from your friends at Johns Hopkins. I know these instant PDF downloads will make a major difference in your prostate health outlook.

But I also know that they only scratch the surface of the wealth of vital information available to you as a subscriber to The Prostate Bulletin. Your subscription will include:

• Four quarterly issues of The Prostate Bulletin, packed with up-to-the-minute health-essential information, delivered promptly to your door via Priority Mail as they are issued.
  
  
• Doctor's Letter reviewing critical prostate developments of the past few weeks. Each issue of The Prostate Bulletinstarts with Dr. Mostwin’s Letter — up to 20 pages of late-breaking news and information about the very latest treatment strategies and early intervention options, plus first-hand reports from urological conferences around the world that are helping men to prolong their lives, and improve their quality of life.
  
  
• In-Depth Reports on prostate health issues ranging from treatment options and preventive measures to prostatectomy techniques and new diagnostic tools. Each report is authored by a recognized expert on its topic — including such medical authorities as Dr. H. Logan Holtgrewe, M.D., former president of the American Urological Association… Dr. Alan W. Partin, M.D., Ph.D., Distinguished Professor of Urologic Oncology at the Johns Hopkins University School of Medicine and editor-in-chief of Urology… Dr. Patrick C. Walsh, M.D., Urologist-in-Chief of the James Buchanan Brady Urological Institute… and literally dozens more who are at the forefront of prostate research and treatment.
  
  
• Participation in our Grand Rounds forum — in which readers have the opportunity to pose specific prostate health questions to Johns Hopkins specialists. While we can’t guarantee that every single question will be answered, typical issues include as many as ten to twelve pages’ worth of readers’ questions and expert answers.
  
  
• 5 FREE Special Reports on important prostate issues, yours to keep even if you decide not to continue with your subscription.
  
  
• Express Delivery helps ensure the timeliest arrival of each quarterly issue. We know what a difference up-to-the-minute health information can make in determining medical outcomes. That’s why each issue of The Prostate Bulletin is rushed to your door via Priority Mail.
  

When it comes to prostate care, information is the best medicine. Order The Prostate Bulletin now, and download and start reading your five FREE Special Reports right away.

Becoming better informed about prostate care is one of the most important commitments you can make — and The Johns Hopkins Prostate Bulletin is the most informative prostate health resource ever published for medical consumers. Don’t miss out on new treatment options and clinical findings that could make a huge difference in your medical outcome — and your family’s peace of mind. Subscribe to The Prostate Bulletin today.

To your health,

Stuart Jordan
Publisher
The Johns Hopkins Prostate Bulletin

P.S. You have my personal guarantee that The Prostate Bulletin must live up to your expectations in terms of its timeliness, informativeness, and usefulness in your medical situation. If you're dissatisfied with your subscription in any way, simply notify Customer Service that you wish to cancel — and you will receive a prompt refund, no questions asked. Keep the five Special Reports with our best wishes.